Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-15
DOI
10.1002/jcp.27505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic and prognostic cytogenetics of chronic myeloid leukaemia: an update
- (2017) Matteo Molica et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Sex chromosome changes in leukemia: cytogenetics and molecular aspects
- (2017) Saeid Shahrabi et al. Hematology
- An unusual translocation, t(1;11)(q21;q23), in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome
- (2017) Leandro Germán Gutiérrez et al. Oncology Letters
- Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature
- (2017) Nicola Sgherza et al. Therapeutics and Clinical Risk Management
- Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
- (2016) W. Wang et al. BLOOD
- Molecular Response of e19a2 BCR-ABL1 Chronic Myeloid Leukemia With Double Philadelphia Chromosome to Dasatinib
- (2016) Kazuhiko Ikeda et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
- (2016) Z Chen et al. LEUKEMIA
- Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia
- (2016) W Wang et al. Blood Cancer Journal
- Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review
- (2016) M.T. Manda-Mapalo et al. Cancer Genetics
- Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
- (2015) W. Wang et al. BLOOD
- Prognostic Factors, Response to Treatment, and Survival in Patients With Chronic Myeloid Leukemia in Blast Phase: A Single-Institution Survey
- (2015) Fernando Pérez-Jacobo et al. Clinical Lymphoma Myeloma & Leukemia
- Chronic myeloid leukaemia
- (2015) Jane F Apperley LANCET
- Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors
- (2015) W Wang et al. LEUKEMIA
- Inhibition of Ras-mediated signaling pathways in CML stem cells
- (2015) Jessika Bertacchini et al. CELLULAR ONCOLOGY
- Increased genomic instability may contribute to the development of kinase domain mutations in chronic myeloid leukemia
- (2014) Kendra Sweet et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
- (2014) Saeid Shahrabi et al. TUMOR BIOLOGY
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia
- (2013) Sureyya Bozkurt et al. MEDICAL ONCOLOGY
- Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population
- (2012) Qitian Mu et al. ANNALS OF HEMATOLOGY
- Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis
- (2012) S. Luatti et al. BLOOD
- A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report
- (2012) Sho Yokota et al. Molecular Cytogenetics
- A significant proportion of patients with chronic myeloid leukemia and suboptimal response according to European Leukemia Net criteria have excellent prognosis without treatment change
- (2011) Peter Rohon et al. BIOMEDICAL PAPERS-OLOMOUC
- Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
- (2011) G. Marzocchi et al. BLOOD
- Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia
- (2011) Laura Cannella et al. LEUKEMIA & LYMPHOMA
- A rare chronic myeloid leukemia case with Philadelphia chromosome, BCR-ABL e13a3 transcript and complex translocation involving four different chromosomes
- (2010) WALID AL ACHKAR et al. Oncology Letters
- Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells
- (2009) Cristian Bellodi et al. JOURNAL OF CLINICAL INVESTIGATION
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
- (2009) Michele Baccarani et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results
- (2009) Francesca Palandri et al. LEUKEMIA & LYMPHOMA
- Translation of the Philadelphia chromosome into therapy for CML
- (2008) B. J. Druker BLOOD
- FISH mapping of Philadelphia negative BCR/ABL1 positive CML
- (2008) Anna Virgili et al. Molecular Cytogenetics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started